Bioline Rx Ltd Adr (BLRX)

Apr 01, 2026

Operating cash flow per share of BioLineRX Ltd. Sponsored ADR – MUN:YP2 - TradingView

Apr 01, 2026

Mar 27, 2026

BioLineRx: Advancing GLIX1 and Motixafortide Pipeline with Strengthened IP and Legal Position Underpinning Buy Rating and $12 Target - tipranks.com

Mar 27, 2026

Mar 27, 2026

BioLineRx launches trial of brain cancer drug GLIX1 By Investing.com - Investing.com South Africa

Mar 27, 2026

Mar 26, 2026

BioLineRx initiates Phase 1/2a study of GLIX1 - tipranks.com

Mar 26, 2026

Mar 26, 2026

BioLineRx Announces Initiation of Phase 1/2a Study of GLIX1 for the Treatment of Glioblastoma (GBM) - Finviz

Mar 26, 2026

Mar 26, 2026

BioLineRx Launches First-in-Human Trial of GLIX1 for Glioblastoma - TipRanks

Mar 26, 2026

Mar 26, 2026

BioLineRx launches trial of brain cancer drug GLIX1 - investing.com

Mar 26, 2026

Mar 23, 2026

BioLineRx provides corporate update - tipranks.com

Mar 23, 2026

Mar 23, 2026

Earnings call transcript: BioLineRx’s Q4 2025 sees revenue drop, stock dips By Investing.com - Investing.com South Africa

Mar 23, 2026

Mar 23, 2026

Earnings call transcript: BioLineRx’s Q4 2025 sees revenue drop, stock dips - Investing.com

Mar 23, 2026

Mar 23, 2026

BioLineRx Reports 2025 Financial Results and Provides Corporate Update - Finviz

Mar 23, 2026

Mar 23, 2026

BioLineRx Sets March Start for GLIX1 Brain Cancer Trial as 2025 Results Show Leaner R&D-Focused Model - TipRanks

Mar 23, 2026

Mar 23, 2026

Going concern and debt pressures at BioLineRx (NASDAQ: BLRX) - Stock Titan

Mar 23, 2026

Mar 19, 2026

Top Wall Street Forecasters Revamp BioLineRx Expectations Ahead Of Q4 Earnings - Sahm

Mar 19, 2026

Mar 16, 2026

BioLineRx to Report 2025 Annual Results on March 23, 2026 - Finviz

Mar 16, 2026

Feb 23, 2026

BioLineRx Wins Arbitration Ruling in Motixafortide Licensing Dispute - TipRanks

Feb 23, 2026

Feb 20, 2026

Analysts’ Top Healthcare Picks: Praxis Precision Medicines (PRAX), Beyond Air (XAIR) - The Globe and Mail

Feb 20, 2026

Feb 13, 2026

Analysts Offer Insights on Healthcare Companies: Harrow Health (HROW), Icon (ICLR) and Perspective Therapeutics (CATX) - The Globe and Mail

Feb 13, 2026

Jan 31, 2026

Analysts Offer Insights on Healthcare Companies: Radiopharm Theranostics Limited Sponsored ADR (RADX) and Resmed (RMD) - The Globe and Mail

Jan 31, 2026

Jan 17, 2026

Analysts Offer Insights on Healthcare Companies: Solventum Corporation (SOLV) and Praxis Precision Medicines (PRAX) - The Globe and Mail

Jan 17, 2026

Jan 14, 2026

Analysts Offer Insights on Healthcare Companies: Argenx Se (ARGX), Travere Therapeutics (TVTX) and Beyond Air (XAIR) - The Globe and Mail

Jan 14, 2026

Dec 06, 2025

Analysts Conflicted on These Healthcare Names: MBX Biosciences, Inc. (MBX), Praxis Precision Medicines (PRAX) and Iovance Biotherapeutics (IOVA) - The Globe and Mail

Dec 06, 2025

Nov 30, 2025

BioLineRx Earnings Call: Strategic Initiatives Amid Revenue Challenges - MSN

Nov 30, 2025

Nov 24, 2025

BioLineRx Reports Q3 2025 Results and Strategic Expansion - TipRanks

Nov 24, 2025

Nov 24, 2025

Earnings call transcript: BioLineRx Q3 2025 earnings reveal significant revenue miss By Investing.com - Investing.com South Africa

Nov 24, 2025

Nov 24, 2025

BioLineRx Announces Q3 2025 Financial Results and New Joint Venture - TipRanks

Nov 24, 2025

Nov 24, 2025

Earnings call transcript: BioLineRx Q3 2025 earnings reveal significant revenue miss - Investing.com India

Nov 24, 2025

Nov 24, 2025

BioLineRx shares rise over 7% on better-than-expected earnings By Investing.com - Investing.com South Africa

Nov 24, 2025

Nov 24, 2025

BioLineRx shares rise over 7% on better-than-expected earnings - Investing.com

Nov 24, 2025

Nov 24, 2025

BioLineRx Reports Third Quarter 2025 Financial Results and Provides Corporate Update - Finviz

Nov 24, 2025

Nov 21, 2025

BioLine Rx's Earnings: A Preview - Sahm

Nov 21, 2025

Nov 19, 2025

BioLineRx stock rises after partner receives key patent allowance By Investing.com - Investing.com India

Nov 19, 2025

Nov 19, 2025

BioLineRx stock rises after partner receives key patent allowance - Investing.com

Nov 19, 2025

Nov 18, 2025

BioLineRx to Report Third Quarter 2025 Results on November 24, 2025 - Finviz

Nov 18, 2025

Nov 17, 2025

BioLineRx stock rises after securing key patent for cancer treatment - Investing.com India

Nov 17, 2025

Nov 17, 2025

BioLineRx Announces Receipt of USPTO Notice of Allowance for Key Patent Covering GLIX1 for Treating a Broad Range of Cancer Types - Finviz

Nov 17, 2025

Nov 17, 2025

BioLineRx Secures USPTO Patent Allowance for Cancer Treatment with GLIX1 - TipRanks

Nov 17, 2025

Nov 17, 2025

BioLineRx receives key patent for cancer treatment GLIX1 - Investing.com India

Nov 17, 2025

Nov 17, 2025

BioLineRx receives key patent for cancer treatment GLIX1 By Investing.com - Investing.com South Africa

Nov 17, 2025

Nov 15, 2025

Analysts’ Top Healthcare Picks: Serina Therapeutics (SER), Cybin (CYBN) - The Globe and Mail

Nov 15, 2025

Nov 14, 2025

Analysts Offer Insights on Healthcare Companies: PDS Biotechnology (PDSB) and Autolus Therapeutics (AUTL) - The Globe and Mail

Nov 14, 2025

Nov 12, 2025

Analysts Are Bullish on These Healthcare Stocks: Beyond Air (XAIR), Diamedica Therapeutics (DMAC) - The Globe and Mail

Nov 12, 2025

Nov 07, 2025

Analysts Offer Insights on Healthcare Companies: Schrodinger (SDGR), Lexicon Pharmaceuticals (LXRX) and Cullinan Management (CGEM) - The Globe and Mail

Nov 07, 2025

Nov 03, 2025

Working capital per share of BioLineRX Ltd. Sponsored ADR – SWB:YP2 - TradingView

Nov 03, 2025

Nov 02, 2025

BioLineRx ADR Earnings Call: Optimism Amid Challenges - MSN

Nov 02, 2025

Oct 18, 2025

Analysts Are Bullish on Top Healthcare Stocks: Abbott Laboratories (ABT), Achieve Life Sciences (ACHV) - The Globe and Mail

Oct 18, 2025

Oct 16, 2025

Cash per share of BioLineRX Ltd. Sponsored ADR – FWB:YP2 - TradingView

Oct 16, 2025

Sep 29, 2025

BioLineRx, Hemispherian AS establish joint venture to develop GLIX1 - TipRanks

Sep 29, 2025